The European Food Safety Authority (EFSA) has asked the Panel on Dietetic Products, Nutrition and Allergies (NDA) to revise the guidance on the scientific requirements for health claims related to physical performance published in 2012. Since then, the NDA Panel has completed the evaluation of Article 13.1 claims (except for claims put on hold by the European Commission) and has evaluated additional health claim applications submitted pursuant to Article 13(5) in the area covered by this guidance. In addition, the NDA Panel has developed the general scientific guidance for stakeholders for health claims applications which addresses general issues that are common to all health claims. To further assist applicants, EFSA launched in 2014 a grant which aimed at gathering information in relation to claimed effects, outcome variables and methods of measurement in the context of the scientific substantiation of health claims. This update takes into account the experience gained by the NDA Panel with the evaluation of additional health claim applications, changes introduced to the general scientific guidance for stakeholders, and information collected from a grant. The guidance is intended to assist applicants in preparing applications for the authorisation of health claims related to muscle function and physical performance. The draft guidance was discussed and endorsed by the NDA Panel on 28 June 2018 for release for public consultation.
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In the last years, the NDA Panel has gained considerable experience in the evaluation of health claim 62 applications. To further assist applicants seeking approval of health claims, EFSA launched in 2014 a
Introduction 83
The Guidance on the scientific requirements for health claims related to physical performance and all three referred to claims other than those based on the essentiality on nutrients: two were on 92 muscle function and one on physical performance (Appendix A).
93
Examples of health claims evaluated by the NDA Panel with a favourable opinion (under Article 13(1)
94
and applications under Article 13(5)) will be used to provide guidance to applicants on the scientific requirements for the substantiation of health claims in specific areas, whereas examples of claims 96 evaluated by the NDA Panel with an unfavourable opinion will be used to illustrate the shortcomings that prevented the substantiation of these claims.
98
To further assist applicants, the information collected from the grant (GP/ 
102

Objectives and scope
This guidance is intended to assist applicants in preparing applications for the scientific substantiation
104
of health claims related to physical performance and muscle function. The document focuses on key 105 issues, particularly:
106
 claimed effects which are considered to be beneficial physiological effects;
107
 definition of the target population for which the claim is intended;
108
 characteristics of human intervention studies which can provide evidence for the scientific 109 substantiation of specific claims addressed in this guidance (e.g. appropriate outcome
110
variables and methods of measurement, suitable study group(s), suitable controls).
111
Issues related to scientific substantiation that are common to all health claims (e.g. principles applied
112
for claims based on the essentiality of nutrients vs. claims other than those based on the essentiality 
145
(e.g. endurance capacity, strenuous exercise, short-term high-intensity exercise). In other instances,
146
terms have not been defined assuming that they had a precise meaning and were well understood in 147 the research field, which may not be so (e.g. muscle fatigue).
148
For the purpose of this guidance, and within the context of the scientific evaluation of health claims in 
154
For the purpose of this guidance, and having regard of the scientific references cited above:
155
Physical activity is defined as any bodily movement produced by skeletal muscles which ). Exercise intensity has also been classified 176 using subjective measures, i.e. relative to the subject's perception of effort, using the Borg's amount of resistance (load). The one repetition maximum (1RM), which is the greatest weight 179 that can be lifted or displaced one time in good form, is relevant for dynamic measurements,
180
whereas the maximal voluntary contraction (MVC) is relevant for isometric measurements.
Frequency in training programs is described as the number of activity sessions per day, week, or month.
Duration refers to the number of minutes of activity in each exercise session (and to the duration of each interval within a session for interval training).
and duration, the main metabolic pathways involved and/or the type of physical fitness targeted (e.g.
191
endurance, cardiorespiratory, flexibility, and neuromuscular exercise; "aerobic and "anaerobic"
192
exercise; sedentary, light, moderate, vigorous and high-intensity exercise; all-out (maximal) efforts:
193
"explosive", "high intensity", "endurance intensive efforts"), the Panel notes that the nomenclature in
194
this field is not harmonised. Therefore, in the context of claims substantiation, the claimed effect (e.g.
195
the testing conditions under which the food/constituent may affect performance) must be described 
202
Muscle contraction is the activation of tension-generating sites within muscle fibres and can
203
be concentric or eccentric.
204
Muscle strength refers to the (maximum) amount of external force that a skeletal muscle
205
(or muscle group) can exert. It may be expressed as MVC for isometric measurements and as
206
the 1RM for dynamic measurements.
207
Endurance is the ability to sustain a physical activity or exercise over a period of time.
208
Muscle endurance refers to the ability of muscle groups to exert and maintain an external
209
force for a number of repetitions or successive exertions against a constant resistance.
210
Muscle fatigue is defined as any exercise-induced reduction in the maximal capacity to 211 generate force or power output, or in the capacity to maintain a pre-defined force or power 212 output.
213
Exercise-induced muscle soreness is an aching sensation following muscular exertion that
214
can be acute (i.e. the immediate ache perceived by the athlete while or immediately after soreness can vary from mild discomfort to incapacitating pain depending on the intensity,
218
volume and novelty of the exercise.
219
Exercise-induced muscle damage refers to the disruption of muscle fibres during exercise 220 which may be associated to a reduction of muscle function. Muscle damage may lead to pain
221
and soreness, but these may also occur in the absence of muscle damage.
222
Mechanical work is the amount of energy transferred by a force acting over a certain 223 distance.
224
Power relates to the rate at which mechanical work can be performed.
225
Physical performance is the ability to complete certain physical tasks. An increase in
226
physical performance refers to completion of a given physical task with higher intensity, and 227 therefore faster or with a higher power output.
228
Physical capacity is the ability to continue a physical activity despite increasing physical or 229 psychological stress, and refers to the exercise time to fatigue when exercising at predefined 230 conditions (e.g. a given load, intensity or speed). 
Claims on muscle function 249
The improvement, maintenance or reduced loss of muscle function (contraction) is considered a 250 beneficial physiological effect. Failure to increase muscle mass during growth and development, and 251 the loss of muscle mass at any age, will impair muscle function (e.g. muscle strength and power).
252
Faster recovery of normal muscle function after exercise is also considered a beneficial physiological 
295
Outcome variables related to body composition (e.g. whole-body lean body mass, muscle mass) or 296 muscle structure (e.g. muscle shape, number and type of muscle fibres, muscle damage, muscle 
336
can provide support for a mechanism by which the food/constituent could exert the claimed effect.
authoritative bodies, which were based on a wealth of human intervention (efficacy) studies, human 341 studies on methods used for measuring muscle glycogen stores, and mechanistic in vitro and animal 342 studies. As for the mode of action, the Panel took into account that it is well-established that glucose,
343
which is mainly provided to body cells from glycaemic carbohydrates, can be stored as glycogen in the 344 liver and in the skeletal muscles, and that muscle glycogen, which is used primarily as a source of 345 energy within the muscles, can only be stored in a limited amount in skeletal muscles. It is also well-346 established that strenuous exercise depletes skeletal muscle glycogen stores, that low glycogen stores 347 limit energy production in muscles and thereby limit skeletal muscle contraction, and that glycaemic 
362
For the scientific substantiation of claims on the effects of specific protein sources/constituents on 363 outcome variables related to muscle mass and muscle function (e.g. muscle strength), human 364 intervention studies assessing the effect of a specific protein source/constituent against another 365 isonitrogenous protein source/constituent were considered as pertinent to the claim, whereas studies 366 controlling for energy only (e.g. using isocaloric carbohydrate sources as placebo) could not be used 
379
and/or perceived fatigue during exercise. Performance parameters were not assessed in those studies.
380
The Panel considered that, while there is consensus on the contribution of training in reducing blood 381 lactate concentrations during and after exercise and on delaying muscle fatigue during exercise, no 382 evidence was provided that lowering blood lactate through a dietary intervention can prevent or 383 alleviate loss of muscle function during exercise or can lead to a faster recovery from muscle fatigue by contributing to the restoration of muscle function after exercise. The Panel also noted that there is 385 no consensus on the role of lactate in the recovery from muscle fatigue.
Claims on physical performance and physical capacity 387
Physical performance is the ability to complete certain physical tasks. An increase in physical 388 performance refers to completion of a given physical task with higher intensity, and therefore faster or 
396
Physical capacity, on the other hand, refers to the exercise time to fatigue when exercising at pre-397 defined conditions (e.g. a given workload, intensity or speed). Exercise time to fatigue is an 398 appropriate measure of physical capacity. An increased physical capacity is a beneficial physiological 399 effect for individuals performing physical exercise which is not limited by time or task (e.g.
400
recreational running, walking, swimming, cycling and fitness training).
401
Although an increase in physical capacity (e.g. the time that an individual can exercise to fatigue at a 
417
The Panel considers that specific physiological effects such as the reduction in the rated perceived 418 exertion/effort during exercise or an enhancement of water absorption during exercise could be the 419 mechanisms by which a food/constituent could exert an effect on physical capacity or performance.
420
However, evidence that the food/constituent has an effect on direct measures of physical capacity or 421 physical performance should also be provided. 
427
The exercise or physical activity under evaluation (e.g. the testing conditions under which the 428 food/constituent may affect performance) needs to be characterised by:
the mode/type of exercise or physical activity. duration, high intensity).
446
The target population for the claim should be sufficiently defined regarding fitness status and/or age
447
(e.g. young athletes, untrained elderly subjects, individuals on resistance training).
448
Outcome variables/methods of measurement of physical performance which may be appropriate for 
452
As for the conditions of use, when the food/constituent should be consumed relative to the physical 453 performance test (e.g. before and/or during exercise), the duration of the intervention, and the need 
486
The scientific substantiation of the claim was based on a wealth of human intervention studies which 
497
A claim on beta-alanine and increase in physical performance during short-duration, high intensity 498 exercise has been evaluated by the Panel with an unfavourable outcome (EFSA NDA Panel, 2014b).
499
Human intervention studies on the effects of beta-alanine on measures of physical capacity (e.g. time 500
to exhaustion and/or total work done and/or physical working capacity at fatigue threshold) in the 501 context of time unlimited physical activities which did not report on any measures of physical 502 performance were excluded from the assessment. The main outcomes investigated in the remaining 503 studies were the time spent to complete a certain task (run, row, swim or cycle a pre-defined 504 distance) and power output in time-limited (all-out or maximal effort) tasks lasting seconds. Overall, 505 no effect of beta-alanine supplementation on measures of physical performance was found.
506
A claim on carbohydrate solutions and increase in physical performance during a high-intensity and 
514
In these studies, trained participants underwent one or more exercise trials of fixed intensity
515
(generally ≥65% of the VO 2max or 70-80% of HR max ) and duration (overall lasting > 60 min), followed
516
by an all-out test in which performance was measured. Different types of exercise (e.g. cycling, 517 running) were used for the pre-test and the test trials, which were either continuous, intermittent, or 518 a combination of these (e.g. a cycling trial before and during the test; four cycling trials of eight 
Claims on physical capacity
532
The scientific evaluation of health claims on physical capacity requires sufficient characterisation of the 533 claimed effect and of the target population for which the claim is made.
534
Physical capacity can be assessed in human intervention studies using several exercise protocols as 535 long as they are not task-or time-limited overall, so that subjects can exercise to fatigue. The on the substantiation of a health claim related to citrulline-malate and faster recovery from muscle on the substantiation of a health claim related to beta-alanine and increase in physical 
